Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
113.00
-3.00 (-2.59%)
At close: Feb 6, 2026

Chiome Bioscience Revenue

Chiome Bioscience had revenue of 118.02M JPY in the quarter ending September 30, 2025, a decrease of -25.73%. This brings the company's revenue in the last twelve months to 727.99M, up 25.28% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.

Revenue (ttm)
727.99M
Revenue Growth
+25.28%
P/S Ratio
10.62
Revenue / Employee
13.74M
Employees
53
Market Cap
7.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024780.81M98.35M14.41%
Dec 31, 2023682.46M51.65M8.19%
Dec 31, 2022630.82M-82.12M-11.52%
Dec 31, 2021712.93M232.08M48.26%
Dec 31, 2020480.85M33.28M7.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Mar 31, 2012 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Linical9.87B
Soiken Holdings4.87B
CellSource3.71B
StemCell Institute2.72B
MEDINET998.00M
OncoTherapy Science956.00M
PRISM BioLab Co.,LTD677.00M
ADR120S49.00M
Revenue Rankings